Qualified Persons hold legal responsibility for certifying that pharmaceutical batches are safe for clinical or commercial release. UK QP supply is structurally short of demand, with the Pharmaceutical Journal noting "a shortage of QPs in the UK" and salaries and contract day rates rising rapidly. Newly registered QPs command £55,000 to £70,000, with experienced QPs reaching £75,000 to £100,000 permanent and £650 to £1,100 per day on contract.
Key Takeaways
- A Qualified Person (QP) is legally responsible for certifying batches of pharmaceutical products are safe for clinical trial use or commercial market release under EU GMP Annex 16 and MHRA inspection standards
- QP eligibility is administered by the Joint Professional Bodies (Royal Pharmaceutical Society, Royal Society of Chemistry, Royal Society of Biology) on behalf of the MHRA and Veterinary Medicines Directorate
- UK QP salaries currently run £55,000 to £70,000 for newly registered QPs, £75,000 to £95,000 with 2+ years post-qualification experience, and £100,000+ at senior or specialist level per Next Phase Recruitment and Pharmaceutical Journal 2026 data
- Contract QP day rates run £650 to £1,100 per day, equivalent to roughly £90 to £100 per hour for self-employed contractor QPs, with rates highest on ATMP and gene therapy batch release
- The UK QP register is held privately by the JPB; the candidate pool is small (low hundreds of active QPs), and counter offer activity at resignation runs above 75 percent
What Does a Qualified Person Actually Do?
A Qualified Person reviews the complete manufacturing and quality control documentation for each batch of pharmaceutical product and certifies that the batch is manufactured in accordance with the Marketing Authorisation, complies with EU GMP, and is safe for release to clinical trials or commercial market. The signature on the QP certificate is the legal release event for every regulated medicine sold in the UK.
The work covers commercial product release at licensed manufacturing sites, clinical trial supply release for Investigational Medicinal Products, ATMP and cell therapy product release at the rapidly expanding UK ATMP cluster, and import certification for products manufactured outside the UK or EU. The QP signature carries personal legal liability under the Medicines for Human Use Regulations and the Human Medicines Regulations 2012.
Who can become a Qualified Person in the UK?
QP eligibility is administered by the Joint Professional Bodies on behalf of the MHRA. Royal Pharmaceutical Society members complete a minimum of one year of supervised practical experience in a licensed unit; Royal Society of Chemistry and Royal Society of Biology members require a minimum of two years. All routes require completion of the prescribed JPB syllabus, professional viva examination, and nomination by an existing QP sponsor.
What's the difference between a QP and a Responsible Person?
A Qualified Person certifies manufactured pharmaceutical product batches under a Manufacturer Authorisation (MIA). A Responsible Person (RP) oversees the storage and distribution of medicines under a Wholesale Dealer's Licence (WDL). The two roles serve distinct regulatory functions and are not interchangeable, though some QPs hold dual RP authorisation where a company operates both manufacturing and distribution.
UK Qualified Person Salary Bands in 2026
Published vacancy rates and salary survey data across UK pharma in 2026:
- Newly registered QP (0 to 2 years post-qualification): £55,000 to £70,000 permanent base. Initial QP positions at smaller manufacturers or as junior QP at larger sites.
- Established QP (2 to 5 years post-qualification): £75,000 to £95,000 permanent base. Lead QP roles at commercial manufacturing sites and primary QP for clinical trial supply units.
- Senior QP / QP Manager (5+ years): £95,000 to £130,000+ permanent base. Senior QP roles at multinational pharma, ATMP specialist roles, and QP Lead at large CDMOs.
- Contract QP (all grades): £650 to £1,100 per day, or £90 to £100 per hour for self-employed contractor QPs. Higher rates apply on ATMP, radiopharmaceutical, and complex sterile product batch release.
Per the ABPI working in industry guide, the average UK QP salary stands at approximately £57,000, with the published range from £40,000 (smaller employers, junior positions) to £90,000+ (senior, specialist, or large multinational pharma). The Pharmaceutical Journal notes salaries "rising rapidly to keep pace with demand."
The QP Pay Negotiation Reality
The structural QP shortage gives existing QPs material negotiating room on internal pay reviews. Industry data shows annual permanent QP salary inflation running at 6 to 10 percent through 2025 and 2026, materially above the wider pharma salary inflation rate of 3 to 4 percent. Newly registered QPs who stay with their training employer often see uplifts of 30 to 50 percent on first post-qualification review.
The candidate-side framework for getting the pay rise you deserve applies more strongly to QPs than to any other UK pharma role given the documented shortage and the legal weight of the certification signature. QPs entering pay conversations with their employer have unusually strong evidence for their case.
UK QP Demand Drivers in 2026
Three structural forces are sustaining the UK QP shortage above the baseline.
ATMP, cell therapy, and gene therapy product approvals have created a fresh demand layer for QPs with biological and cellular product experience. The MHRA approved several novel ATMP products in 2025 and 2026, with the UK manufacturing cluster at Stevenage Bioscience Catalyst, the Cell and Gene Therapy Catapult Stevenage, Sci-Tech Daresbury, and the Edinburgh ATMP hub all hiring across QP roles.
Pharmaceutical manufacturing reshoring under the UK Life Sciences Vision has added new licensed manufacturing facilities across the North West, East of England, and Scotland. Each new MIA requires nominated QPs, with site capacity creating sustained hiring demand.
Radiopharmaceutical product growth, including the Siemens Healthineers Nottingham radiopharma facility currently recruiting Qualified Person (Radiopharma) roles, has created a specialist demand stream within the broader QP market. Radiopharmaceutical QPs are among the rarest cohorts in UK pharma.
On-Site Presence and Flexibility for QP Roles
QP batch release certification requires physical access to the manufacturing site, the batch records, and the materials being certified. Unlike most senior pharma roles, the certification step itself cannot be performed remotely. This creates a structural constraint on QP working patterns that employers are increasingly building flexibility around.
UK pharma manufacturers are responding with hybrid models: compressed on-site weeks (3 to 4 days), shared QP cover arrangements across sister sites, and contract QP rotations to absorb peak release demand. The wider pattern of how on-site businesses can adapt to a flexible working environment is particularly visible in the QP segment, where retention pressure has forced employers to engineer flexibility around the legally mandated on-site requirement.
How to Hire Qualified Persons in the UK
Scantec's QP recruitment methodology runs five steps, drawing on the wider quality and compliance candidate map across UK pharma manufacturing.
Step 1: Map the live QP candidate pool against your product type. The total UK QP register sits in the low hundreds. Active QPs with experience matching your product type (small molecule, biological, ATMP, radiopharma, veterinary, clinical trial supply) form a much smaller subset. We map the addressable pool against your specific requirements before the role goes to advert.
Step 2: Plan for the trainee QP pathway as an alternative route. Where the active QP pool is exhausted, sponsoring a senior QA or QC specialist through the QP training pathway is a viable 12 to 24 month route. The candidate must be employed at a licensed manufacturing unit with QP sponsor support throughout the training period.
Step 3: Build the package beyond headline salary. Senior QPs typically have stronger response to total package and progression rather than salary alone. Bonus structure, share scheme access (where available), ATMP product portfolio exposure, employer indemnity coverage on the QP signature, and progression to QP Lead or Quality Director all matter. The principle that workplace benefits matter as much as headline pay is unusually well-evidenced in the QP recruitment market.
Step 4: Differentiate Inside and Outside IR35 for contract QPs. Contract QP engagements at £650 to £1,100 per day predominantly run Outside IR35 because the QP signature carries personal legal responsibility and the engagement structure typically supports the determination. The April 2026 Joint and Several Liability legislation has not changed this materially.
Step 5: Pre-empt the counter offer. UK QPs receive counter offers at resignation in 75 to 85 percent of cases. The retention argument needs equipping with the candidate's true decision factors (product portfolio breadth, ATMP exposure, employer reputation, indemnity structure, progression scope) rather than only headline salary.
Frequently Asked Questions
How do you become a Qualified Person in the UK?
Eligibility runs through the Joint Professional Bodies (Royal Pharmaceutical Society, Royal Society of Chemistry, Royal Society of Biology). Candidates need a relevant science degree, employment at a licensed manufacturing unit, a QP sponsor, completion of the prescribed JPB syllabus (typically 12 to 24 months), and a successful professional viva. The MHRA approves the final nomination.
How long does QP training take in the UK?
Royal Pharmaceutical Society route: minimum 1 year of supervised practical experience plus syllabus completion. Royal Society of Chemistry and Royal Society of Biology routes: minimum 2 years of supervised experience plus syllabus completion. Most candidates complete the full process in 18 to 30 months, including the viva preparation period.
What's the average UK QP salary in 2026?
Average UK QP salary stands at approximately £57,000 per ABPI 2024 data, with newly registered QPs at £55,000 to £70,000 and experienced QPs at £75,000 to £95,000+ per Next Phase Recruitment 2026. Senior and specialist QPs at large multinational pharma exceed £100,000. The Pharmaceutical Journal confirms salaries are rising rapidly given the structural QP shortage.
What does a contract QP charge per day?
Contract QP day rates run £650 to £1,100 per day across UK pharma, with higher rates applying on ATMP, radiopharmaceutical, sterile injectable, and complex biological product batch release. Self-employed contractor QPs typically charge £90 to £100 per hour, with the rate structure depending on the contract length, product complexity, and whether the QP holds additional specialist qualifications.
Can a QC Analyst or QA Specialist become a QP?
Yes. The standard career path into QP runs through senior QA or QC roles at a licensed manufacturing unit, with QP sponsorship from an existing QP at the site. The trainee QP completes the JPB syllabus and supervised practical experience while continuing to perform QA or QC duties, then progresses to fully nominated QP on successful viva and MHRA approval.
Are radiopharmaceutical QPs different from standard QPs?
The professional qualification is the same, but the practical experience required for nomination includes radiopharmaceutical-specific competency. Radiopharma QPs are particularly rare given the small number of UK radiopharmaceutical manufacturers (Siemens Healthineers Nottingham, GE HealthCare, Curium, regional NHS units), and command premium rates accordingly.
Hiring Qualified Persons in the UK?
Scantec specialises in QP recruitment across UK pharma, biotech, ATMP, radiopharmaceutical, and clinical trial supply. Contact us to brief a permanent or contract QP requirement.
